MIST
Milestone Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · CA
$1.20
−0.72%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 14.30x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.21x
- Price / sales
- 63.83x
- Price / cash flow
- -2.44x
Enterprise value
- Enterprise value
- $120.8M
- EV / sales
- 51.55x
- EV / EBITDA
- -1.65x
- EV / EBIT
- -1.54x
- Market cap
- $149.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026